Clinical trial
The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients…
NCT00045760 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00045760 |
|---|---|
| Title | The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | Drotrecogin alfa (activated) |
| Start date | Sep 1, 2002 |
| First posted | Sep 10, 2002 |
| Last update posted | Jul 20, 2006 |
| Countries | Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, Egypt, Finland, France, Germany and 20 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: